Agile vial filling capacity for personalized medicines, clinical trial supplies and drug development
Flexible filling of vials, syringes and cartridges for clinical and commercial drug products
Flexibility for liquid or lyophilized drug products in vials, syringes or cartridges
Are you looking for an aseptic fill/finish solution for your multi-product portfolio? See the Microcell Vial Filler live and in action at Interphex! Our team of experts are looking forward to discussing how you can create agile filling operations while bringing your injectable medicines to market faster.Connect with Vanrx at Interphex
NNE’s latest article appearing on Pharmaceutical Online focuses on regulatory opinion around aseptic production technology, including VHP sterilization. Regulatory authorities are increasing the pressure to remove human intervention from biopharma aseptic filling, resulting in fully automated systems.Read More
Download a white paper to learn how Vanrx can help solve your operational and strategic problems.
How Aseptic Filling Workcells will change your operations.
A "big picture" look at manufacturing strategies for speed to market and flexibility.
Highly agile technologies for filling of personalized medicines like cell and gene therapies.
On November 6 at AAPS, Markus Stübchen, Roche’s Global Technical Lead for Large Molecule Drug Product & Clean Utilities, delivered the presentation Novel Approaches for Robotics Use in Sterile Manufacturing. The presentation described how Roche / Genentech will use Vanrx's SA25 as part of a "network" strategy.Read More
On November 6, 2018, Dr. Nitin Rathore, Director of Process Development at Amgen, presented 'Implementation of Next-Generation Technologies in Biomanufacturing' at the American Association of Pharmaceutical Scientists (AAPS) Pharma 360 conference in Washington, D.C.Read More
Deloitte has named Vanrx Pharmasystems as the fastest growing technology company in Canada on its 2018 Technology Fast 50 list. The Fast 50 program celebrates innovation in the form of rapid revenue growth. Vanrx’s revenue growth percentage was 19,342%, placing it first on the overall list.Read More
Gloveless robotic isolators for vials of clinical trial supplies and commercial drug products
Gloveless robotic isolators for drug products in pre-filled syringes (PFS)
Gloveless robotic isolators for pharmaceutical cartridge filling for auto-injectors
Mar 18 - Mar 19, 2019
North Bethesda, MD, USA
Apr 2 - Apr 4, 2019
New York, NY, USA
Apr 28 - May 2, 2019
Vancouver, BC, Canada
Our team members have developed and brought complex drug products to market. We know what you need now, and are designing for the future.